Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association studyIsabelle Cleynen, Charlie W. Lees, Richard H. Duerr et al.|The Lancet|2015Cited by 779
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genesYukihide Momozawa, Judy H. Cho, Julia Dmitrieva et al.|Nature Communications|2018Cited by 252
Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort StudyVince Biemans, Frank Hoentjen, Andrea E. van der Meulen‐de Jong et al.|Journal of Crohn s and Colitis|2019Cited by 183
Prior Colorectal Neoplasia Is Associated With Increased Risk of Ileoanal Pouch Neoplasia in Patients With Inflammatory Bowel DiseaseLauranne Derikx, Frank Hoentjen, Wietske Kievit et al.|Gastroenterology|2013Cited by 134
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatmentVince Biemans, C. Janneke van der Woude, Gerard Dijkstra et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 129